Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients
NCT04584606 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-10-14
Summary
COVID-19 as a novel disease, different disease patterns were observed worldwide, and many treatment plans were tried. So, it is important to investigate the Egyptian clinical characteristics and different factors that determine the patient's 'outcome
Conditions
- Coronavirus Disease (COVID-19)
Interventions
- DIAGNOSTIC_TEST
-
Lab workup (on admission and regularly during follow up).
Complete blood count with differential leucocytic count. Absolute lymphocytic and neutrophilic count. Liver functions: Aspartate transaminase and Alanine transaminase . Renal functions: Blood urea nitrogen, serum Creatinine. HbA1C. C-reactive protein (quantitative). Serum ferritin level. D - dimer level (quantitative). Coagulation profile (Prothrombin time/ Partial thromboplastin time/ International normalized ratio). Troponin level. Arterial blood gases when needed.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Ashraf Elmaraghy · Ain Shams University, Faculty of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-27
- Primary Completion
- 2020-10-31
- Completion
- 2020-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Persistence of Symptoms After Improvement of Acute COVID-19
NCT04764773 ·Status: COMPLETED
-
The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals
NCT04548492 ·Status: UNKNOWN
-
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
NCT04668469 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Sirolimus in COVID-19 Infection
NCT04461340 ·Status: UNKNOWN ·Phase: PHASE2
-
Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt
NCT04488588 ·Status: COMPLETED
-
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
NCT04535869 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
NCT04739345 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt
NCT04816942 ·Status: COMPLETED ·Phase: PHASE3
-
Ivermectin In Treatment of COVID 19 Patients
NCT04425707 ·Status: UNKNOWN ·Phase: NA
-
Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
NCT04438694 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Impact of Steroids on Inflammatory Response in Covid-19
NCT04909918 ·Status: COMPLETED ·Phase: PHASE3
-
A Registry Study of Patients Hospitalized With Confirmed COVID-19
NCT05792865 ·Status: UNKNOWN
-
Plasma Rich Antibodies From Recovered Patients From COVID19
NCT04348877 ·Status: UNKNOWN ·Phase: NA
-
A Simple Approach to Prevent Hospitalization for COVID-19 Patients
NCT04854824 ·Status: COMPLETED
-
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
NCT04376788 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Favipiravir in Management of COVID-19
NCT04349241 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Faviprevir in COVID-19 Treatment
NCT04351295 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Lipid Emulsion Infusion and COVID-19 Patients
NCT04957940 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
NCT04738045 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study
NCT06006611 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
NCT04528927 ·Status: WITHDRAWN ·Phase: PHASE3
-
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
NCT04447534 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
NCT04530422 ·Status: COMPLETED ·Phase: PHASE3
-
Colchicine and Post-COVID-19 Pulmonary Fibrosis
NCT04818489 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
NCT04734678 ·Status: COMPLETED